TOP TIERMARKET NEWSWIRE
SEC Form 4 history

KARYOPHARM THERAPEUT (KPTI) insider trades

KARYOPHARM THERAPEUT (KPTI) insider trading activity (SEC Form 4). Over the trailing 90 days, KPTI insiders filed 0 purchases totalling $0 and 7 sales totalling $36K — net SELLING of $36K. Most recent filing: Jul 30, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
7
$36K
Net (90d)
-$36K
net selling
Most recent
Jul 30, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Jul 30, 2026Poulton StuartEVP, Chief Development OfficerS Sale—$7.10$1Kfiling
May 15, 2026Cheng Sohanya RoshanEVP, Chief Commercial OfficerS Sale—$9.50$3Kfiling
May 15, 2026Rangwala ReshmaEVP, Chief Medical OfficerS Sale—$9.50$4Kfiling
May 15, 2026Poulton StuartEVP, Chief Development OfficerS Sale—$9.50$4Kfiling
May 15, 2026Mano MichaelEVP, CLO, SecretaryS Sale—$9.50$3Kfiling
May 15, 2026Paulson Richard A.Pres, CEOS Sale—$9.50$21Kfiling
May 15, 2026Abate KristinChief Accounting OfficerS Sale—$9.50$504filing